Search

Your search keyword '"Miguel Angel Calleja"' showing total 57 results

Search Constraints

Start Over You searched for: Author "Miguel Angel Calleja" Remove constraint Author: "Miguel Angel Calleja" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
57 results on '"Miguel Angel Calleja"'

Search Results

1. The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner in colon and breast cancer cells.

6. The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD)

8. Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain

9. High serum levels of ustekinumab are associated with better clinical outcomes during maintenance treatment for inflammatory bowel disease

10. Therapeutic Value of Single Nucleotide Polymorphisms on the Efficacy of New Therapies in Patients with Multiple Sclerosis

11. Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi‐Criteria Decision Analysis

12. Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results

13. Accuracy of enteral syringes with commonly prescribed paediatric liquid medicines

14. Audit of a multidisciplinary approach to improve management of community-acquired pneumonia

15. Effects of virgin olive oils differing in their bioactive compound contents on biomarkers of oxidative stress and inflammation in healthy adults: a randomized double-blind controlled trial

16. Adherence of nutritional support prescriptions to clinical practice guidelines in patients with anorexia nervosa

17. The impact of implementing a pharmacy technician role as part of a nursing team in an acute admissions unit

18. [Program for the adaptation of the use of paracetamol to lower and safer doses: Implementation and results]

19. Farmacogenómica de etanercept, infliximab, adalimumab y metotrexato en artritis reumatoide. Revisión estructurada

20. Clinical pharmacy services: from cost-effectiveness analysis to a productivity indicators model

21. Value of α‑fetoprotein as an early biomarker for treatment response to sorafenib therapy in advanced hepatocellular carcinoma

22. Loss of efficacy and safety of the switch from infliximab original to infliximab biosimilar (CT-P13) in patients with inflammatory bowel disease

23. Effects of virgin olive oils differing in their bioactive compound contents on metabolic syndrome and endothelial functional risk biomarkers in healthy adults: a randomized double-blind controlled trial

24. Study of the effectiveness of first-line treatment in renal cell carcinoma

25. Effectiveness of the bevacizumab-irinotecan regimen in the treatment of recurrent glioblastoma multiforme: Comparison with other second-line treatments without this regimen

26. Drug tolerability in assisted reproduction techniques: a longitudinal study

27. Asociación entre el sindrome coronario agudo y el consumo de antiinflamatorios no esteroideos

28. Results of treatment with alemtuzumab in a Spanish cohort of patients with multiple sclerosis in the real world: The RealMS study

29. The antioxidant effect of β-caryophyllene protects rat liver from carbon tetrachloride-induced fibrosis by inhibiting hepatic stellate cell activation

30. Value of α‑fetoprotein as an early biomarker for treatment response to sorafenib therapy in advanced hepatocellular carcinoma.

31. Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis

32. The Chemotherapeutic Drug 5-Fluorouracil Promotes PKR-Mediated Apoptosis in a p53- Independent Manner in Colon and Breast Cancer Cells

33. DPYD variant testing in candidates for fluoropyrimidine treatment: A study protocol

34. A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study)

35. Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH)

37. SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain’s hospital pharmacy departments

38. Pharmacist recommendations for carbapenem de-escalation in urinary tract infection within an antimicrobial stewardship program

39. Real clinical impact of drug–drug interactions of immunosuppressants in transplant patients

41. Effectiveness of the bevacizumab-irinotecan regimen in the treatment of recurrent glioblastoma multiforme: Comparison with other second-line treatments without this regimen

43. Clinical outcomes of carbapenem de-escalation regardless of microbiological results: A propensity score analysis

44. Trends in endpoint selection and result interpretation in advanced non‐small cell lung cancer clinical trials published between 2000 and 2012: A retrospective cohort study

45. Good clinical and cost outcomes using dexrazoxane to treat accidental epirubicin extravasation

46. Proposal for the Creation of a National Strategy for Precision Medicine in Cancer: a position statement of SEOM, SEAP and SEFH

47. Development of integrated support software for clinical nutrition

48. Asociación entre el síndrome coronario agudo y el consumo de antiinflamatorios no esteroideos

49. MAPEX: look deeper, looking away

50. The NUTRAOLEOUM Study, a randomized controlled trial, for achieving nutritional added value for olive oils

Catalog

Books, media, physical & digital resources